Benfotiamine shows up on a lot of supplement labels with the word "anti-inflammatory" close by. The laboratory science behind that word is real. The human science is thinner than most labels admit.
I want to walk through what the research actually shows, and just as importantly, what it does not. This is one of those cases where the honest answer is more interesting than the hyped one, and where the credibility comes from naming the limits out loud.
What is benfotiamine?
Benfotiamine is a modified form of vitamin B1, also called thiamine. It is widely described as fat-soluble, which is not accurate: Volvert and colleagues, 2008, found it practically insoluble in water, organic solvents and oil. It absorbs well anyway, by being cleaved at the intestinal wall rather than by dissolving in fat. Because it dissolves in fat rather than water, the body tends to absorb more of it per dose than ordinary water-soluble thiamine (Balakumar and colleagues, 2010). Inside cells it helps activate an enzyme called transketolase, which is part of normal glucose metabolism.
That last part is basic biochemistry, not a health claim. Thiamine is an essential vitamin your nerves and cells use to turn food into energy. The fat-soluble version was designed to get more of it into the bloodstream. Researchers have described that better absorption as the reason it became interesting to study in the first place (Balakumar and colleagues, 2010; Raj and colleagues, 2018).
One thing up front, so you can weigh everything that follows: benfotiamine is one of the ingredients in BellyMD's Calm, and I am the physician who formulated it. Read the rest the way you would read anyone discussing their own product. My aim here is to tell you where the evidence is strong and where it runs out, not to sell you on a headline.
How might benfotiamine affect inflammation?
In laboratory studies using cells and animals, benfotiamine has been shown to influence inflammatory signaling, including a master switch called NF-kB, short for nuclear factor kappa B. In those models it lowered two inflammatory messengers, TNF-alpha (tumor necrosis factor alpha) and IL-6 (interleukin-6), compared with controls (Yadav and colleagues, 2011; Yadav and colleagues, 2015).
NF-kB is one of the main controls the body uses to switch inflammation on and off. TNF-alpha and IL-6 are two of the signals inflammation sends when it is running. In dishes and in animals, benfotiamine appears to quiet that signaling. It also keeps activating transketolase, the glucose-metabolism enzyme, which is part of how researchers think the effect might work (Balakumar and colleagues, 2010; Raj and colleagues, 2018).
Here is the honest caveat. A cell in a dish is not a person, and an animal is not a person either. Mechanism tells you a plausible story about how something could work. It does not tell you that it works in you.
What does the human research on benfotiamine and inflammation show?
Not much yet, and it does not all agree. One small randomized trial in 2025, in adults with type 2 diabetes, reported modest reductions in inflammatory markers compared with placebo. Those markers included TNF-alpha, IL-6, and high-sensitivity C-reactive protein, or CRP (2025 randomized trial). An earlier randomized trial found no significant change (Alkhalaf and colleagues, 2012).
Two small trials pointing in opposite directions is not a settled answer. It is a sign the question is still open. When studies disagree, the honest move is to say the evidence is mixed, not to quote the result you happen to like and leave the other one out.
Will benfotiamine lower inflammation for me?
Honestly, no one can promise that. The people studied were mostly patients with diabetes who started with high inflammation. A healthy person starting from a low baseline may not respond the same way. Researchers have noted that findings in that group may not carry over to everyone else (Alkhalaf and colleagues, 2012).
This is the part most supplement copy skips. A result found in sick patients with a lot of room to improve does not automatically apply to a healthy person who has little inflammation to begin with. It might. We do not know yet. Anyone who tells you the diabetes-trial numbers are what you personally will get is selling, not reporting.
The most a supplement can honestly say is that an ingredient supports a healthy inflammatory response, which is a statement about normal function, not a promise to fix a disease. And for the record: these statements have not been evaluated by the Food and Drug Administration. Benfotiamine is a dietary supplement ingredient and is not intended to diagnose, treat, cure, or prevent any disease.
What to do
- Treat the word "anti-inflammatory" on any supplement label as marketing, not proof, and ask what the human evidence looks like rather than the lab mechanism alone.
- If benfotiamine interests you, look at the actual human trials, and notice how few there are and how small they are.
- Talk with your own clinician before adding any supplement, especially if you live with diabetes or another chronic condition.
- Track how you actually feel over weeks, not days, and trust your own log over any promise printed on a bottle.
- Judge a supplement by what it honestly supports in normal function, not by the disease it quietly hints it can fix.
The honest supplement is the one that tells you where the evidence stops.